Novo Nordisk wants to keep its crown leading the weight loss drugs pack—despite outlook downgrades and lawsuits, its CFO has a plan
"The ultimate defence in our industry is in innovation," Knudsen told Fortune in an exclusive interview.
© Fortune
visit website